FOXO3 and breast cancer: The reprogrammed pDCs then promote Treg expansion by expressing forkhead box O3 (FOXO3) and inducible costimulatory molecule ligands, and therefore pDCs infiltration is correlated with poor prognosis in breast cancer patients [220–223].